http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022223226-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e345c8d1967f7a3c35bb4fb8be90615
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-20
filingDate 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49cd7ede9ba93116205998473669c3f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ba7f0c2024baf8f0a4aa757f8a80e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c197da296ef69011f1f9989b2fd512
publicationDate 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022223226-A1
titleOfInvention Methods for detecting and characterizing microsatellite instability with high throughput sequencing
abstract The characterization, classification and reporting of MSI status of patient genomic samples may be provided by high throughput genomic analysis of a set of microsatellite marker loci. The patient sample may only comprise a low fraction of somatic DNA relative to germline DNA. A multi-parametric background model may be used to infer at least two parameters respectively characterizing the sample variant fraction and the MSI genomic alterations of the patient DNA sample relative to a reference background model of the MSS repeat length distribution, without the need to use a germline control sample. A local MSI score may be calculated as a function of the at least two parameters to characterize the MSI status at each locus, and a global composite MSI score may be calculated over all tested loci to characterize and report the overall MSI status for the patient sample. The proposed methods facilitate the deployment of high-throughput genomic data analysis testing for large pools of patients with comparable sensitivity and specificity to prior art biological MSI-status characterization assays.
priorityDate 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7726
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424468465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454006091

Total number of triples: 25.